0.55 (8.27%)Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Weak
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
LENZ Therapeutics, Inc.
Telephone
1.858.925.7000
Address
Suite 300, 201 Lomas Santa Fe Drive, Solana Beach, CA 92075
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 6.61 - 50.4
Trade Value (12mth)
US$4,731,530.00
1 week
-9.4%
1 month
-32.62%
YTD
-58.44%
1 year
-76.38%
All time high
238.00
EPS 3 yr Growth
-77.90%
EBITDA Margin
-476.00%
Operating Cashflow
-$69m
Free Cash Flow Return
-28.30%
ROIC
-33.50%
Interest Coverage
0.00
Quick Ratio
14.10
Shares Outstanding (Fully Diluted)
31m
HALO Sector
Healthcare
Next Company Report Date
24-Mar-27
Next Ex Dividend Date
22-Mar-24
Next Dividend Pay Date
21-Mar-24
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 12 May 26 | |
| 12 May 26 | |
| 12 May 26 | |
| 12 May 26 | |
| 08 January 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -35.71 | -2.34 | -2.85 | | | | ||
EPS (Fully Diluted) | $ | | | | | -35.71 | -2.34 | -2.85 | | | | ||
Growth | % | | | | | -177.1 | 93.5 | -21.9 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
